Guotian Luo

Dr. Guotian Luo

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2019 in Stem Cells
Verified
Journal Article
Closed access
GSGiuliana E. Salazar-Noratto
Giuliana E. Salazar-Noratto
GLGuotian Luo
Guotian Luo
CDCyprien Denoeud
Cyprien Denoeud
MPMathilde Padrona
Mathilde Padrona
AMAdrien Moya
Adrien Moya
HPHervé Petite
Hervé Petite

1 March 2016 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
Ziqing LiZiqing Li
Ziqing Li
CLChaohong Li
Chaohong Li
YZYuhuan Zhou
Yuhuan Zhou
WCWeishen Chen
Weishen Chen
GLGuotian Luo
Guotian Luo
SPSheng Puyi
Sheng Puyi
Advanced glycation end products (AGEs) disturb bone remodeling during aging, and this process is accelerated in diabetes. However, their role in modulation of osteoclast-induced bone resorption is controversial, with some studies indicating that AGEs enhance bone resorption and others showing the opposite effect. We determined whether AGEs present at different stages of osteoclast differentiation affect bone resorption differently. Based on increased levels of tartrate-resistant acid phosphatase (TRAP) and cathepsin K (CTSK), we identified day 4 of induction as the dividing time of cell fusion stage and mature stage in RAW264.7 cell-derived osteoclast-like cells (OCLs). AGE-modified BSA (50–400 μg/ml) or control BSA (100 μg/ml) was then added at the beginning of each stage. Results showed that the presence of AGEs at the cell fusion stage reduced pit numbers, resorption area, and CTSK expression. Moreover, expression of receptor activator of nuclear factor-κB (RANK) as well as the number of TRAP-positive cells, nuclei per OCL, actin rings, and podosomes also decreased. However, the presence of AGEs at the mature stage enlarged the resorption area markedly and increased pit numbers slightly. Intriguingly, only the number of nuclei per OCL and podosomes increased. These data indicate that AGEs biphasically modulate bone resorption activity of OCLs in a differentiation stage-dependent manner. AGEs at the cell fusion stage reduce bone resorption dramatically, mainly via suppression of RANK expression in osteoclast precursors, whereas AGEs at the mature stage enhance bone resorption slightly, most likely by increasing the number of podosomes in mature OCLs.

15 February 2016 in Inflammation
Verified
Journal Article
Closed access
PDF file
GLGuotian Luo
Guotian Luo
Ziqing LiZiqing Li
Ziqing Li
YWYu Wang
Yu Wang
HWHaixing Wang
Haixing Wang
ZZZiji Zhang
Ziji Zhang
SPSheng Puyi
Sheng Puyi

2 January 2018 in Inflammation
Verified
Journal Article
Closed access
PDF file
YXYinbo Xiao
Yinbo Xiao
CLChaohong Li
Chaohong Li
MGMinghui Gu
Minghui Gu
HWHaixing Wang
Haixing Wang
WCWeishen Chen
Weishen Chen
SPSheng Puyi
Sheng Puyi

26 March 2015 in Cellular Physiology and Biochemistry
Verified
Journal Article
Open access
WCWeishen Chen
Weishen Chen
Ziqing LiZiqing Li
Ziqing Li
YGYing Guo
Ying Guo
YZYuhuan Zhou
Yuhuan Zhou
ZZZiji Zhang
Ziji Zhang
SPSheng Puyi
Sheng Puyi
Background/Aims: Prosthesis loosening is closely associated with chronic inflammatory cytokine secretion by macrophages, which are activated by wear particles or inflammatory stimulants such as lipopolysaccharide (LPS). Reactive oxygen species (ROS) are critical regulators of inflammation, but their enzymatic sources in response to wear particles and their effects on peri-implant LPS-tolerance remain unclear. Methods: Three ROS-related enzymes—nicotinamide adenine dinucleotide phosphate oxidase (NOX)-1 and -2 and catalase—were investigated in interface membrane tissues and in titanium (Ti) particle-stimulated macrophages in vitro. The generation of ROS and downstream inflammatory effects were measured with or without pre-incubation with apocynin, an NOX inhibitor. Results: Pre-exposure to Ti particles attenuated NF-κB activation in LPS-stimulated macrophages, indicating that wear particles suppress immune response, which may lead to chronic inflammation. NOX-1 and -2 were highly expressed in aseptically loosened interface membranes and in macrophages stimulated with Ti particles; the particles induced a moderate amount of ROS generation, NF-κB activation, and TNF-a secretion in macrophages, and these effects were suppressed by apocynin. Conclusion: Wear particles induce ROS generation through the NOX signaling pathway, resulting in persistent inflammation and delayed loosening. Thus, the suppression of NOX activity may be a useful strategy for preventing prosthesis loosening.

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
HWHaixing WANG
Haixing WANG
GYGuangpu Yang
Guangpu Yang
YXYinbo Xiao
Yinbo Xiao
GLGuotian Luo
Guotian Luo
GLGang Li
Gang Li
Ziqing LiZiqing Li
Ziqing Li
Heightened activity of osteoclast is considered to be the culprit in breaking the balance during bone remodeling in pathological conditions, such as osteoporosis. As a “foe” of skeletal health, many antiosteoporosis therapies aim to inhibit osteoclastogenesis. However, bone remodeling is a dynamic process that requires the subtle coordination of osteoclasts and osteoblasts. Severe suppression of osteoclast differentiation will impair bone formation because of the coupling effect. Thus, understanding the complex roles of osteoclast in maintaining proper bone remodeling is highly warranted to develop better management of osteoporosis. This review aimed to determine the varied roles of osteoclasts in maintaining skeletal health and to highlight the positive roles of osteoclasts in maintaining normal bone remodeling. Generally, osteoclasts interact with osteocytes to initiate targeted bone remodeling and have crosstalk with mesenchymal stem cells and osteoblasts via secreted factors or cell‐cell contact to promote bone formation. We believe that a better outcome of bone remodeling disorders will be achieved when proper strategies are made to coordinate osteoclasts and osteoblasts in managing such disorders.